BUB1B and glioblastoma: BUB1B was revealed as essential for GSC expansion [79] and GBM displaying sensitivity to BUB1B inhibition (BUB1BS) had a worse prognosis when compared to tumors resistant to BUB1B inhibition (BUB1BR), regardless of molecular subtype.